OncoTherapy Science (TSE:4564) Other Net Income (Loss) : 円0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2003. Start your Free Trial

What is OncoTherapy Science Other Net Income (Loss)?

OncoTherapy Science's Other Net Income (Loss) for the three months ended in Sep. 2024 was 円0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was 円0.0 Mil.

OncoTherapy Science's quarterly Other Net Income (Loss) increased from Dec. 2023 (円-0.0 Mil) to Mar. 2024 (円0.0 Mil) but then declined from Mar. 2024 (円0.0 Mil) to Sep. 2024 (円0.0 Mil).

OncoTherapy Science's annual Other Net Income (Loss) increased from Mar. 2022 (円-0.0 Mil) to Mar. 2023 (円-0.0 Mil) and increased from Mar. 2023 (円-0.0 Mil) to Mar. 2024 (円0.0 Mil).

OncoTherapy Science Other Net Income (Loss) Historical Data

The historical data trend for OncoTherapy Science's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoTherapy Science Other Net Income (Loss) Chart

OncoTherapy Science Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Net Income (Loss)

Get a 7-Day Free Trial

OncoTherapy Science Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

OncoTherapy Science Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

OncoTherapy Science Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of OncoTherapy Science's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoTherapy Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

30O:Germany

Address

11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012

Website

http://www.oncotherapy.co.jp

OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

OncoTherapy Science Headlines

No Headlines